Hubert D[au] - Search Results

Year	Number of Results
1962	1
1965	1
1978	1
1979	1
1980	2
1981	2
1983	2
1984	6
1985	7
1986	1
1987	1
1988	1
1989	1
1990	1
1992	3
1993	1
1994	4
1995	8
1996	3
1997	2
1998	3
1999	5
2000	4
2001	10
2003	8
2004	12
2005	10
2006	9
2007	5
2008	6
2009	17
2010	10
2011	12
2012	7
2013	7
2014	10
2015	7
2016	15
2017	6
2018	4
2019	2
2020	3
2021	7
2022	0

1

Erratum à l'article « Nouvelles thérapeutiques de la mucoviscidose ciblant le gène ou la protéine CFTR » [Rev. Mal. Respir. (2016). doi: 10.1016/j.rmr.2015.11.010].

Hubert D, Bui S, Marguet C, Colomb-Jung V, Murris-Espin M, Corvol H, Munck A. Hubert D, et al. Rev Mal Respir. 2016 Jun;33(6):558. doi: 10.1016/j.rmr.2016.02.005. Epub 2016 Apr 23. Rev Mal Respir. 2016. PMID: 27117927 French. No abstract available.

2

[New therapeutic developments in cystic fibrosis].

Bui S, Macey J, Fayon M; « nouvelles thérapeutiques de la Société Française pour la Mucoviscidose », Bihouée T, Burgel PR, Colomb V, Corvol H, Durieu I, Hubert D, Marguet C, Mas E, Munck A, Murris-Espin M, Reix P, Sermet-Gaudelus I. Bui S, et al. Among authors: hubert d. Arch Pediatr. 2016 Dec;23(12S):12S47-12S53. doi: 10.1016/S0929-693X(17)30062-3. Arch Pediatr. 2016. PMID: 28231894 Review. French.

3

Antibiotic treatment of CF lung disease: from bench to bedside.

Bals R, Hubert D, Tümmler B. Bals R, et al. Among authors: hubert d. J Cyst Fibros. 2011 Jun;10 Suppl 2:S146-51. doi: 10.1016/S1569-1993(11)60019-2. J Cyst Fibros. 2011. PMID: 21658633 Free article. Review.

4

Clinical response to lumacaftor-ivacaftor in patients with cystic fibrosis according to baseline lung function.

Burgel PR, Durieu I, Chiron R, Mely L, Prevotat A, Murris-Espin M, Porzio M, Abely M, Reix P, Marguet C, Macey J, Sermet-Gaudelus I, Corvol H, Bui S, Biouhee T, Hubert D, Munck A, Lemonnier L, Dehillotte C, Silva JD, Paillasseur JL, Martin C; French Cystic Fibrosis Reference Network study group. Burgel PR, et al. Among authors: hubert d. J Cyst Fibros. 2021 Mar;20(2):220-227. doi: 10.1016/j.jcf.2020.06.012. Epub 2020 Jun 24. J Cyst Fibros. 2021. PMID: 32591294

5

Real-World Long-Term Ivacaftor for Cystic Fibrosis in France: Clinical Effectiveness and Healthcare Resource Utilization.

Hubert D, Marguet C, Benichou J, DeSouza C, Payen-Champenois C, Kinnman N, Chandarana K, Munck A, Fajac I; BRIO Study Group. Hubert D, et al. Pulm Ther. 2021 Dec;7(2):455-468. doi: 10.1007/s41030-021-00158-5. Epub 2021 Jun 8. Pulm Ther. 2021. PMID: 34101145 Free PMC article.

6

Emergence of Macrolide-Resistant Mycoplasma pneumoniae during an Outbreak in a Primary School: Clinical Characterization of Hospitalized Children.

Hubert D, Dumke R, Weichert S, Welker S, Tenenbaum T, Schroten H. Hubert D, et al. Pathogens. 2021 Mar 10;10(3):328. doi: 10.3390/pathogens10030328. Pathogens. 2021. PMID: 33802078 Free PMC article.

7

Real-Life Safety and Effectiveness of Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis.

Burgel PR, Munck A, Durieu I, Chiron R, Mely L, Prevotat A, Murris-Espin M, Porzio M, Abely M, Reix P, Marguet C, Macey J, Sermet-Gaudelus I, Corvol H, Bui S, Lemonnier L, Dehillotte C, Da Silva J, Paillasseur JL, Hubert D; French Cystic Fibrosis Reference Network Study Group. Burgel PR, et al. Among authors: hubert d. Am J Respir Crit Care Med. 2020 Jan 15;201(2):188-197. doi: 10.1164/rccm.201906-1227OC. Am J Respir Crit Care Med. 2020. PMID: 31601120

8

Aspergillus fumigatus in the cystic fibrosis lung: pros and cons of azole therapy.

Burgel PR, Paugam A, Hubert D, Martin C. Burgel PR, et al. Among authors: hubert d. Infect Drug Resist. 2016 Sep 20;9:229-238. doi: 10.2147/IDR.S63621. eCollection 2016. Infect Drug Resist. 2016. PMID: 27703383 Free PMC article. Review.

9

Planning operating-theatre suites.

ESSEX-LOPRESTI M, HUBERT D. ESSEX-LOPRESTI M, et al. Among authors: hubert d. Br Med J. 1962 May 26;1(5290):1470-3. doi: 10.1136/bmj.1.5290.1470. Br Med J. 1962. PMID: 13890823 Free PMC article. No abstract available.

10

Correction to: Real-World Long-Term Ivacaftor for Cystic Fibrosis in France: Clinical Effectiveness and Healthcare Resource Utilization.

Hubert D, Marguet C, Benichou J, DeSouza C, Payen-Champenois C, Kinnman N, Chandarana K, Munck A, Fajac I; BRIO Study Group. Hubert D, et al. Pulm Ther. 2021 Dec;7(2):469-470. doi: 10.1007/s41030-021-00165-6. Pulm Ther. 2021. PMID: 34260039 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results